Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-06-06
1998-03-17
Lankford, Jr., Leon B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 54, 514 61, 514825, 514885, 514886, 514921, A61K 31715
Patent
active
057286850
ABSTRACT:
Compounds and methods of making them having the following formula are described which bind to selectin receptors and thus modulate the course of inflammation, cancer and related diseases by modulating cell-cell adhesion events: ##STR1## wherein each R.sup.1 is independently H or lower alkyl (1-4C); R.sup.2 is H, OH or lower alkyl (1-4C), or a lipophilic group such as a higher alkyl group (5-15C), alkylaryl or one or more additional saccharide residues;
REFERENCES:
patent: 4661345 (1987-04-01), Tuomanen
patent: 4994441 (1991-02-01), Neeser
patent: 5580662 (1996-12-01), Rosen et al.
patent: 5580858 (1996-12-01), Ippolito et al.
Kojima, "Inhibition of Selectin-Dependent Tumor Cell Adhesion to Endothelial Cells and Platelets by Blocking O-Glycosylation of these Cells," Biochem. Biophys. Res. Comm. 182(3):1288-1295 (1992).
Kojima et al., J. Biol. Chem. 264(34):20159-20162 (1989).
Kojima et al., J. Biol. Chem. 264(16):9476-9484 (1989).
Lemieux et al., J. of Am. Chem. Soc. 97(14):4069-4076 (1975).
Lis et al., Ann. Rev. Biochem. 55:35-67 (1986).
Ma et al., "Monoclonal Antibody to L-Selectin Attenuates Neutrophil Accumulation and Protects Ischemic Reperfused Cat Myocardium," Circulation 88(2):649-658 (1993).
McEver, "GMP-140: A receptor for Neutrophils and Monocytes on Activated Platelets and Endothelium," J. of Cell. Biochem. 45:156-161 (1991).
Mulligan et al., "Role of Endothelial-Leukocyte Adhesion Molecule 1 (Elam-1) in Neutrophil-mediated Lung Injury in Rats," J. Clin. Invest. 88:1396-1406 (1991).
Sato et al., Carb. Res. 155:c6-c10 (1986).
Shur, J. Biol. Chem. 257(12):6871-6878 (1982).
Simpson, "Reduction of Experimental Canine Myocardial Reperfusion Injury by a Monoclonal Antibody (Anti-Mol, Anti-CD11b) That Inhibits Leukocyte Adhesion," J. Clin. Invest. 81:624-629 (1988).
Smith et al., "Leukocyte Adhesion Molecules and Myocardial Ischemia," TMC 1(4):167-170 (1990).
Varki, "Selectins and other mammalian sialic acid-binding lectins," Current Opinion in Cell Biology 4:257-266 (1992).
Vedder et al., "Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear," Proc. Natl. Acad. Sci. USA 87:2643-2646 (1990).
Weyrich et al., "In Vivo Neutralization of P-Selectin Protects Feline Heart and Endothelium in Myocardial Ischemia and Reperfusion Injury," J. Clin. Invest. 91:262-2629 (1993).
Whistler et al. (eds.), Methods in Carb. Chem. pp. 426-429 (1972).
Winn, "Anti-P-Selectin Monoclonal Antibody Attenuates Reperfusion Injury to the Rabbit Ear," J. Clin. Invest. 92:2042-2047 (1993).
Yamazaki et al., "Expression of Intercellular Adhesion Molecule-1 in Rat Heart with Ischemia Reperfusion and Limitation in Infarct Size by Treatment with Antibodies against Cell Adhesion Molecules," Amer. Journal of Path. 143(2):410-418 (1993).
Yuen et al., "Sulfated Blood Group Lewis.sup.1 A Superior Oligosaccharide Ligand for Human E-Selection," J. Biol. Chem. 3:1595-1598 (1994).
Yuen et al., "Novel Sulfated Ligands for the Cell Adhesion Molecule E-Selectin Revealed by the Neoglycolipid Technology among O-Linked Oligosaccharides on an Ovarian Cystadenoma Glycoprotein," published by American Chemical Society pp. 9126-9131 (1992).
Bevilacqua et al., "Identification of an inductible endothelial-leukocyte adhesion molecule," Proc. Natl. Acad. Sci. USA 84:9238-9242 (1987).
Bird et al., Devel. Biol. 104:449-460 (1984).
Chandrasekaran et al., Abstract--Abstracts of the 11th International Symposium on Glycoconjugates (Jun. 30-Jul. 5, 1991).
Cumar et al., "Isolation and Identification of a Lactose Phosphate Ester from Cow Colostrum", Biochem. & Biophys. Res. Comm., vol. 20 (No. 1), pp. 60-62 (1965).
Dasgupta et al., Carb. Res. 177:c13-c17 (1988).
Edgington, "How sweet it is: Selectin Mediating Drugs," Biotechnology 10:383-389 (1992).
Entman et al., "Inflammation in the course of early myocardial ischemia," FASEB J. 5:2529-2537 (1991).
Feizi, "Oligosaccarides that mediate mammalian cell-cell adhesion," Current Opinion in Structural Biology 3:701-710 (1993).
Fenderson et al., Dev. Biol. 122:21-34 (1987).
Fenderson et al., Differentiation 38:124-133 (1988).
Fenderson et al., J. Exp. Med. 160:1591-1596 (1984).
Fernandez-Mayorales et al., Car. Res. 140:81-91 (1985).
Fernandez-Mayorales et al., Car. Res. 154:93-101 (1986).
Foxall et al., "The Three Members of the Selectin Receptor Family Recognize a Common Carbohydrate Epitope, the Sialyl Lewis.sup.x Oligosaccaride," J. Cell Biol. 117(4):895-902 (1992).
Gabius et al., Anticancer Res. 6:573-578 (1986).
Geng et al., "Rapid neutrophil adhesion to activated endothelium mediated by GMP-140," Nature 343:757-760 (1990).
Gooi et al., Nature 292:156-158 (1981).
Green et al., "High Affinity binding of the leucocyte adhesion L-Selectin to 3'-sulphated-1 c.sup.a and 1e.sup.x oligosaccharides and the predominance of sulphate in this interaction demonstrated by binding studies with a series of lipid-linked oligosaccharides,"Biochem. Biophys. Res. Comm. 188(1):244-251 (1992).
Hakomori et al., Biochem. Biophys. Res. Comm. 100(4):1578-1586 (1981).
Jain et al., "A Convenient Synthesis of o-.alpha.-L-fucopyranosyl-(1.fwdarw.2)-o-.beta.-D galactopyranosyl-(1.fwdarw.4)-D glucopyranose (2'-o-.alpha.-L-fucopyranosyllactose)," published by Elsevier Science Publishers B.V., (1991) pp. c-1 to c-3.
Abbas Saeed A.
Asa Darwin
Dasgupta Falguni
Musser John H.
Nashed Mina A.
Glycomed Incorporated
Lankford , Jr. Leon B.
Prats Francisco C.
LandOfFree
Methods of treating inflammation using cell adhesion inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating inflammation using cell adhesion inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating inflammation using cell adhesion inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-957700